Literature DB >> 19995688

[Cancer epidemiology in France in 2010, comparison with the USA].

S Guérin1, C Hill.   

Abstract

In 2007, a total number of 149,000 cancer deaths were observed in France, 89,100 in the male population and 60,600 in the female population, and in 2009, the number of new diagnoses of cancer is estimated to be 346,500, 197,500 among men and 149,000 among women. The most frequent cancers are prostate, lung and colorectal cancers in men, and breast, colorectal and lung cancers in women. Cancer mortality is higher in France than in the USA for men and lower for women. The largest differences between the two countries are observed for lung cancer and for head and neck (mouth, pharynx, larynx and oesophagus) cancers in men. Lung cancer mortality is higher in the USA than in France for men and much higher for women. These differences are explained by the difference in past tobacco consumption. For head and neck cancers in men, despite a very large decrease in France due mostly to the reduction in alcohol consumption, mortality remains today higher in France than in the USA.

Entities:  

Mesh:

Year:  2010        PMID: 19995688     DOI: 10.1684/bdc.2010.1013

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  7 in total

1.  Health-related quality of life among long-term survivors of colorectal cancer: a population-based study.

Authors:  Agnès Caravati-Jouvenceaux; Guy Launoy; Delphine Klein; Michel Henry-Amar; Edwige Abeilard; Arlette Danzon; Astrid Pozet; Michel Velten; Mariette Mercier
Journal:  Oncologist       Date:  2011-10-10

2.  Clinical characteristics and prognostic factors of prostate cancer with liver metastases.

Authors:  HaiTao Wang; BaoGuo Li; PengYu Zhang; YanHong Yao; JiWu Chang
Journal:  Tumour Biol       Date:  2014-01

3.  Sexuality after breast cancer: cultural specificities of Tunisian population.

Authors:  Mnif Leila; Charfi Nada; Chaabene Kais; Masmoudi Jawaher
Journal:  Pan Afr Med J       Date:  2016-09-20

4.  2011-2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France.

Authors:  Philippe Gorphe; Pierre Blanchard; Gabriel C T E Garcia; Marion Classe; Caroline Even; Stéphane Temam; Ingrid Breuskin
Journal:  BMC Cancer       Date:  2022-09-20       Impact factor: 4.638

5.  Satisfaction with fertility- and sexuality-related information in young women with breast cancer--ELIPPSE40 cohort.

Authors:  Ali Ben Charif; Anne-Déborah Bouhnik; Dominique Rey; Magali Provansal; Blandine Courbiere; Bruno Spire; Julien Mancini
Journal:  BMC Cancer       Date:  2015-08-05       Impact factor: 4.430

6.  Factors associated with the survival of prostate cancer patients with rectal involvement.

Authors:  Haitao Wang; Yanhong Yao; Baoguo Li
Journal:  Diagn Pathol       Date:  2014-02-20       Impact factor: 2.644

7.  Resectable pancreatic adenocarcinoma neo-adjuvant FOLF(IRIN)OX-based chemotherapy - a multicenter, non-comparative, randomized, phase II trial (PANACHE01-PRODIGE48 study).

Authors:  Lilian Schwarz; Dewi Vernerey; Jean-Baptiste Bachet; Jean-Jacques Tuech; Fabienne Portales; Pierre Michel; Antonio Sa Cunha
Journal:  BMC Cancer       Date:  2018-07-24       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.